Xcout IntelMythic Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Mythic Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Mythic Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Mythic Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
Mythic Therapeutics, Inc. at a glance
Mythic Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $29.9M in December 2024. Xcout tracks 6 named people at Mythic Therapeutics, Inc., including George Eliades (Chief Executive Officer).
Mythic Therapeutics, Inc. leadership
- George EliadesChief Executive Officer
- Brian FiskeExecutive Officer
- George EliadesExecutive Officer
- Sandra PooleExecutive Officer
- Bryan RobertsDirector
- Peter HechtDirector
Mythic Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $29.9M | — | |
| Series B | $103M | 10 named | |
| SEC Form D filing | $18.8M | — | |
| Series A | $24M | 2 named | |
| SEC Form D filing | $4.7M | — | |
| Seed | $4.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Mythic Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Mythic Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Biotech
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Similar biotechnology company
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Similar biotechnology company
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Biotech
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Biotech
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Similar biotechnology company
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Similar biotechnology company
Centrose LLC is a biotechnology company that develops a next-generation antibody-drug conjugate platform known as Extracellular Drug Conjugates (EDCs). These precision medicines target the cell surfaceome by binding multiple extracellular proteins simultaneously without cell internalization or drug release, aiming to create safer and more potent treatments for cancer and drug-resistant tumors.
Biotech
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
Similar biotechnology company
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Similar biotechnology company
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Mythic Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mythic Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →